Package Leaflet: Information for the User
Escitalopram Grindeks 5mg film-coated tablets EFG
Escitalopram Grindeks 10mg film-coated tablets EFG
Escitalopram Grindeks 20mg film-coated tablets EFG
escitalopram
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Escitalopram Grindeks contains the active substance escitalopram. Escitalopram belongs to a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs). These medicines work in the brain by increasing the level of a chemical called serotonin.
Escitalopram is used to treat depression (major depressive episodes) and anxiety disorders (such as panic disorder, with or without agoraphobia, social anxiety disorder, generalized anxiety disorder, and obsessive-compulsive disorder).
It may take two weeks for you to start feeling better. Continue to take escitalopram even if it takes some time to start feeling better.
You should see your doctor if you do not feel better or if you feel worse.
Do not take Escitalopram Grindeks:
Warnings and precautions
Tell your doctor or pharmacist before you start taking escitalopram. Inform your doctor if you have any other condition or disease, as your doctor may need to take this into account. In particular, tell your doctor:
Be aware that
Some patients with manic-depressive illness may enter a manic phase, characterized by an unusual and rapid change of ideas, euphoria, and excessive physical activity. If you experience these symptoms, contact your doctor.
Symptoms such as restlessness or difficulty sitting or standing may continue to occur during the first few weeks of treatment. Tell your doctor immediately if you experience these symptoms.
Medicines like escitalopram (also called SSRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms have persisted after stopping treatment.
Suicidal thoughts and worsening of depression or anxiety
If you are depressed or have anxiety disorders, you may sometimes think about harming or killing yourself. These thoughts may increase when you first start taking antidepressant treatment, as all these medicines take time to work, usually about two weeks or longer.
You may be more likely to have these thoughts if:
If at any time you have thoughts of harming or killing yourself, contact your doctor or go to the hospital immediately.
It may be helpful to tell a relative or close friendthat you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Children and adolescents
Escitalopram Grindeks is not usually recommended for children and adolescents under 18 years of age. You should also know that patients under 18 years of age are at increased risk of side effects, such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, oppositional behavior, and anger) when taking this type of medicine. However, your doctor may prescribe escitalopram to patients under 18 years of age if they decide it is the best treatment for them. If your doctor has prescribed Escitalopram Grindeks to a patient under 18 years of age and you want to discuss this, contact your doctor again. You should tell your doctor if the patient under 18 years of age who is taking escitalopram experiences any of the above symptoms or if they get worse. Additionally, the long-term effects of escitalopram on growth, maturity, and cognitive and behavioral development in this age group have not yet been demonstrated.
Other medicines and Escitalopram Grindeks
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Tell your doctor if you are taking any of the following medicines:
Do not take escitalopram if you are taking medicines to treat heart rhythm problems or medicines that may affect the heart rhythm, such as class IA and III antiarrhythmics, antipsychotics (e.g., phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, certain antimicrobials (e.g., sparfloxacin, moxifloxacin, intravenous erythromycin, pentamidine, antimalarial treatment, especially halofantrine), and certain antihistamines (astemizole, hydroxyzine, mizolastine). If you have any other questions about the use of this medicine, ask your doctor.
Taking Escitalopram Grindeks with food, drinks, and alcohol
Escitalopram Grindeks can be taken with or without food (see section 3).
As with many other medicines, it is not recommended to combine escitalopram and alcohol, although it is not expected that escitalopram will interact with alcohol.
Pregnancy, breast-feeding, and fertility
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not take escitalopram if you are pregnant or breast-feeding, unless you and your doctor have discussed the benefits and risks.
If you take Escitalopram Grindeks during the last 3 months of pregnancy, you should be aware that your baby may have the following symptoms: difficulty breathing, blue discoloration of the skin, seizures, inadequate temperature regulation, feeding difficulties, vomiting, low blood sugar, muscle stiffness or hypotonia, increased reflexes, tremors, nervousness, irritability, lethargy, persistent crying, and sleep disturbances. If your baby has any of these symptoms, contact your doctor immediately.
Make sure to inform your midwife or doctor that you are taking escitalopram. Taking medicines like escitalopram, especially in the last 3 months of pregnancy, may increase the risk of the newborn baby having a serious condition called "persistent pulmonary hypertension of the newborn" (PPHN), which makes the baby breathe faster and turn blue. These symptoms usually start in the first 24 hours of the baby's life. If your baby has these symptoms, you should contact your midwife or doctor immediately.
If you take escitalopram at the end of pregnancy, there may be an increased risk of vaginal bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should be aware that you are taking escitalopram so they can advise you.
Escitalopram should never be stopped abruptly during pregnancy.
It is expected that escitalopram will be excreted in breast milk.
Studies in animals with citalopram, a medicine like escitalopram, have shown a reduction in sperm quality. This could affect fertility, although the effect on human fertility has not been observed yet.
Driving and using machines
During treatment with Escitalopram Grindeks, you may feel drowsy or dizzy. Do not drive or use tools or machines until you know how the treatment with escitalopram affects you.
Escitalopram Grindeks contains sodium.
This medicine contains less than 23 mg of sodium (1 mmol) per dose, which is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Adults
Depression
The recommended dose of escitalopram is usually 10 mg in a single dose per day. Your doctor may increase the dose up to a maximum of 20 mg per day.
Anxiety Disorder
The starting dose of escitalopram is a single dose of 5 mg per day for the first week, before increasing the dose to 10 mg per day. Your doctor may increase the dose later up to a maximum of 20 mg per day.
Social Anxiety Disorder
The recommended dose of escitalopram is usually 10 mg in a single dose per day. Your doctor may decrease the dose to 5 mg per day or increase the dose up to a maximum of 20 mg per day, depending on the response to the medication.
Generalized Anxiety Disorder
The recommended dose of escitalopram is usually 10 mg in a single dose per day. Your doctor may increase the dose up to a maximum of 20 mg per day.
Obsessive-Compulsive Disorder
The recommended dose of escitalopram is usually 10 mg in a single dose per day. Your doctor may increase the dose up to a maximum of 20 mg per day.
Elderly patients (over 65 years old)
The recommended starting dose of escitalopram is usually 5 mg in a single dose per day. Your doctor may increase the dose up to 10 mg per day.
Use in children and adolescents
Escitalopram should not be administered to children or adolescents. If you want more information, consult the "Warnings and precautions" section of section 2.
Renal impairment
Caution is advised in patients with severely impaired renal function. Follow the administration instructions for the medication exactly as indicated by your doctor.
Hepatic impairment
Patients with hepatic disorders should not receive more than 10 mg per day. Follow the administration instructions for the medication exactly as indicated by your doctor.
Poor metabolizers of the CYP2C19 enzyme
Patients with this genotype should not receive more than 10 mg per day. Follow the administration instructions for the medication exactly as indicated by your doctor.
How to take the tablets
You can take escitalopram with or without food. Swallow the tablets with a little water. Do not chew the tablets, they have a bitter taste.
If necessary, you can divide the tablets into equal doses; to do this, place the tablet on a flat surface with the scored side of the tablet facing up. Then you can divide the tablets, pressing with your thumbs on each end, as shown in the figure.
Only the 10 mg and 20 mg tablets can be divided into equal doses.
Duration of treatment
It may take two weeks before you start to feel better. Continue taking escitalopram, even if it takes some time before you experience any improvement in the disease you are suffering from.
Do not change the dose of your medication without discussing it with your doctor first.
Continue taking escitalopram for the time recommended by your doctor. If you interrupt your treatment too early, the symptoms may return. It is recommended to continue treatment for at least 6 months after you feel better again.
If you take more Escitalopram Grindeks than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 915 620 420, indicating the medication and the amount ingested, even if you do not experience signs of discomfort. Some signs of overdose may be: dizziness, tremors, agitation, convulsions, coma, nausea, vomiting, alteration of heart rhythm, decrease in blood pressure, and variation in hydroelectrolytic balance. When you go to the doctor or hospital, take the box or packaging of Escitalopram Grindeks with you.
If you forget to take Escitalopram Grindeks
Do not take a double dose to make up for forgotten doses. If you forget to take a dose and remember before going to bed, take it immediately and continue taking the medication at your usual time the next day. If you remember during the night or the next day, do not take the forgotten dose and continue with your usual dosing schedule.
If you stop treatment with Escitalopram Grindeks
Do not stop taking escitalopram until your doctor tells you to. When you finish your treatment cycle, it is generally recommended that the dose of escitalopram be gradually reduced over several weeks.
When you stop taking escitalopram, especially if you do so abruptly, you may experience withdrawal symptoms. These symptoms are common when treatment with escitalopram is discontinued. The risk is greater when treatment with escitalopram has been prolonged, high doses have been taken, or when the dose is reduced too quickly. Most people experience mild symptoms that resolve on their own within two weeks. However, the intensity of these symptoms can be severe in some patients or may be more prolonged (2-3 months or more). If you experience severe withdrawal symptoms when stopping treatment with escitalopram, contact your doctor. They may ask you to start taking the tablets again to reduce the dose more slowly.
The symptoms of withdrawal syndrome include: dizziness (instability or loss of balance), feeling of muscle aches, burning sensation, and (less frequently) sensations of electric discharge, even in the head, sleep disturbances (vivid dreams, nightmares, insomnia), anxiety, headache, feeling of dizziness (nausea), sweating (including night sweats), restlessness or agitation, tremors (agitation), confusion or disorientation, emotional instability or irritability, diarrhea (loose stools), visual disturbances, fluttering or strong heartbeat (palpitations).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Side effects usually resolve within a few weeks of treatment. You should keep in mind that many of the effects can also be symptoms of the disease you are suffering from and, therefore, will improve as you start to feel better.
If you experience any of the following symptoms, you should contact your doctor or go to the hospital immediately:
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from available data):
In addition to the above side effects, the following have also been reported:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from available data):
It is also known that certain side effects can occur with drugs that work similarly to escitalopram (the active ingredient of Escitalopram Grindeks). These are:
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects that do not appear in this leaflet. You can also report them directly through the Spanish Medicines Surveillance System for Human Use: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not store at a temperature above 30°C.
Do not use this medication after the expiration date that appears on the box and blister after "EXP". The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy or in any other Medication Waste Collection System. If you have any doubts, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Escitalopram Grindeks
The active ingredient is escitalopram. Each film-coated tablet contains escitalopram oxalate, equivalent to 5 mg, 10 mg, or 20 mg of escitalopram.
The other ingredients are:
Core:microcrystalline cellulose (E-460), sodium croscarmellose (E-468), hypromellose (E-464), talc (E-553b), anhydrous colloidal silica (E-551), and magnesium stearate (E-470b).
Coating:hypromellose (E-464), macrogol, and titanium dioxide (E-171).
Appearance of the product and package contents
Escitalopram Grindeks 5 mg is a film-coated tablet, white to off-white, round, biconvex, and approximately 6 mm in diameter.
Escitalopram Grindeks 10 mg is a film-coated tablet, white to off-white, oval, biconvex, approximately 8 mm x 6 mm, with the inscription 1 and 0 engraved on each side of the score line on one face.
Escitalopram Grindeks 20 mg is a film-coated tablet, white to off-white, oval, biconvex, approximately 12 mm x 7 mm, with a score line on one face.
Escitalopram Grindeks is available in PVC/PE/PVDC//Al or OPA/Al/PVC//Al blisters of 14, 28, 30, 56, 98, or 100 film-coated tablets.
Only some pack sizes may be marketed.
Marketing authorization holder
AS GRINDEKS.
Krustpils iela 53, Riga, LV-1057, Latvia
Tel: +371 67083205
E-mail: grindeks@grindeks.lv
Manufacturer
AS GRINDEKS.
Krustpils iela 53, Riga, LV-1057, Latvia
HBM Pharma s.r.o.
Sklabinská 30
Martin, 03680
Slovakia
You can request more information about this medication by contacting the local representative of the marketing authorization holder
Grindeks Kalceks España, S.L.
C/ José Abascal, 58 – 2º Dcha.
Madrid, 28003, Spain
This medication is authorized in the member states of the European Economic Area with the following names:
Sweden | Escitalopram Grindeks |
Austria | Escitalopram Grindeks 5 mg, 10 mg, 20 mg Filmtabletten |
Belgium | Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets |
Bulgaria | ???????????? ???????? 5 mg, 10 mg, 20 mg ????????? ???????? Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets |
Croatia | Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets |
Czech Republic | Escitalopram Grindeks |
Estonia | Escitalopram Grindeks |
France | ESCITALOPRAM GRINDEKS 5 mg, film-coated tablet ESCITALOPRAM GRINDEKS 10 mg, scored film-coated tablet ESCITALOPRAM GRINDEKS 20 mg, scored film-coated tablet |
Germany | Escitalopram Grindeks 5 mg, 10 mg, 20 mg Filmtabletten |
Greece | Escitalopram/Grindeks 5 mg, 10 mg, 20 mg ????????? ??????????? ????????? |
Hungary | Escitalopram Grindeks 5, 10 és 20 mg filmtabletta |
Ireland | Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets |
Italy | Escitalopram Grindeks |
Latvia | Escitalopram Grindeks 5 mg, 10 mg, 20 mg apvalkotas tabletes |
Lithuania | Escitalopram Grindeks 5 mg plevele dengtos tabletes Escitalopram Grindeks 10 mg plevele dengtos tabletes Escitalopram Grindeks 20 mg plevele dengtos tabletes |
Luxembourg | Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmomhulde tabletten |
Netherlands | Escitalopram Grindeks 5 mg filmomhulde tabletten Escitalopram Grindeks 10 mg filmomhulde tabletten Escitalopram Grindeks 20 mg filmomhulde tabletten |
Norway | Escitalopram Grindeks |
Poland | Escitalopram Grindeks |
Portugal | Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets |
Romania | Escitalopram Grindeks 5 mg, 10 mg, 20 mg comprimate filmate |
Slovakia | Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmom obalené tablety |
Slovenia | Escitalopram Grindeks 5 mg, 10 mg, 20 mg filmsko obložene tablete |
Spain | Escitalopram Grindeks 5 mg, 10 mg, 20 mg film-coated tablets EFG |
Date of last revision of this leaflet: May 2023.
Other sources of information
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)